News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2026|
Sales Effectiveness
Advertisement

Frontage Labs

Advertisement

Articles by Frontage Labs

Twenty Years of Growth

ByFrontage Labs
July 15th 2021

Sponsored Podcast

Learn how Frontage Laboratories started, recent growth and expansion, and the future vision of Frontage

Twenty Years of Growth at Frontage Labs

ByFrontage Labs
July 15th 2021
Advertisement

Latest Updated Articles

  • Twenty Years of Growth
    Twenty Years of Growth

    July 15th 2021



Advertisement
Advertisement

Trending on PharmExec

1

UCB Enters $2.2 Billion Agreement to Acquire Candid Therapeutics

2

Pharmaceutical Executive Daily: UCB to Acquire Candid Therapeutics

3

Scaling Innovation Without Losing Executional Rigor: Q&A with Mark Thierer

4

How a Shifting Landscape is Making Affordable DTP At Scale a Reality

5

Asembia ASX26: How Payers are Embracing Value-Based Care Models for Cell & Gene Therapies

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us